サマリー

市場分析と洞察。ナノ粒子薬物送達システムの世界市場
ナノ粒子薬物送達システムの世界市場規模は、2020年の4億8900万米ドルから、2021-2027年の間に10％のCAGRで、2027年には8億300万米ドルに達すると予測しています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のナノ粒子薬物送達システム市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができます。その中には、収益面での世界のナノ粒子ドラッグデリバリーシステム市場の全体的なサイズも含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界のナノ粒子薬物送達システム市場で永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のナノ粒子薬物送達システム市場を詳細に調査するために、ユニークで業界最高の調査・分析アプローチを採用しました。
世界のナノ粒子薬物送達システムの範囲と市場規模
ナノ粒子薬物送達システム市場は、プレイヤー別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のナノ粒子薬物送達システム市場のプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント分析では、2016年から2027年までの期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。
企業別
ジョンソン・エンド・ジョンソン
サン・ファーマシューティカル
CSPC
Kinyond
Teva
復旦-張江
Zydus Cadila
TTYバイオファーマ
パキラ
Luye Pharma
Leadiant Biosciences
イプセン
Sayre Therapeutics
ジャズ
アルナイラム
バウシュ・ヘルス
アクロテック・バイオファーマ
武田薬品
チエジ・ファルマチェウティチ
ギリアド・サイエンシズ
タイプ別セグメント
リポソーム医薬品
脂質ナノ粒子医薬品
アプリケーション別
病院
小売薬局
その他
地域別
北アメリカ
アメリカ
カナダ
メキシコ

アジア太平洋
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国

ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
その他のヨーロッパ諸国

南米
ブラジル
その他の南アメリカ諸国

中近東・アフリカ
中近東
アフリカ

ページTOPに戻る

目次

1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Nanoparticle Drug Delivery Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1
1.2.2 Liposomes Drugs 3
1.2.3 Lipid Nanoparticle Drugs 4
1.3 Market by Application 5
1.3.1 Global Nanoparticle Drug Delivery Systems Market Share by Application: 2016 VS 2021 VS 2027 6
1.3.2 Hospital 6
1.3.3 Retail Pharmacy 7
1.4 Study Objectives 8
1.5 Years Considered 8
2 GLOBAL GROWTH TRENDS 9
2.1 Global Nanoparticle Drug Delivery Systems Market Perspective (2016-2027) 9
2.2 Nanoparticle Drug Delivery Systems Growth Trends by Regions 10
2.2.1 Nanoparticle Drug Delivery Systems Market Size by Regions: 2016 VS 2021 VS 2027 10
2.2.2 Nanoparticle Drug Delivery Systems Historic Market Size by Regions (2016-2021) 12
2.2.3 Nanoparticle Drug Delivery Systems Forecasted Market Size by Regions (2022-2027) 12
2.3 Nanoparticle Drug Delivery Systems Industry Dynamic 13
2.3.1 Nanoparticle Drug Delivery Systems Market Trends 13
2.3.2 Nanoparticle Drug Delivery Systems Market Drivers 17
2.3.3 Nanoparticle Drug Delivery Systems Market Challenges 18
2.3.4 Nanoparticle Drug Delivery Systems Market Restraints 18
3 COMPETITION LANDSCAPE BY KEY PLAYERS 21
3.1 Global Top Nanoparticle Drug Delivery Systems Players by Revenue 21
3.1.1 Global Top Nanoparticle Drug Delivery Systems Players by Revenue (2019-2021) 21
3.1.2 Global Nanoparticle Drug Delivery Systems Revenue Market Share by Players (2019-2021) 22
3.2 Global Nanoparticle Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) 23
3.3 Players Covered: Ranking by Nanoparticle Drug Delivery Systems Revenue 24
3.4 Global Nanoparticle Drug Delivery Systems Market Concentration Ratio 25
3.4.1 Global Nanoparticle Drug Delivery Systems Market Concentration Ratio (CR5 and HHI) 25
3.4.2 Global Top 5 Companies by Nanoparticle Drug Delivery Systems Revenue in 2020 27
3.4.3 Global Top 10 Companies by Nanoparticle Drug Delivery Systems Revenue in 2020 28
3.5 Nanoparticle Drug Delivery Systems Key Players Head office and Area Served 28
3.6 Key Players Nanoparticle Drug Delivery Systems Product Solution and Service 29
3.7 Founded Date of Nanoparticle Drug Delivery Systems Players 30
3.8 Mergers & Acquisitions, Expansion Plans 31
4 NANOPARTICLE DRUG DELIVERY SYSTEMS BREAKDOWN DATA BY TYPE 32
4.1 Global Nanoparticle Drug Delivery Systems Historic Market Size by Type (2016-2021) 32
4.2 Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Type (2022-2027) 33
5 NANOPARTICLE DRUG DELIVERY SYSTEMS BREAKDOWN DATA BY APPLICATION 35
5.1 Global Nanoparticle Drug Delivery Systems Historic Market Size by Application (2016-2021) 35
5.2 Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Application (2022-2027) 36
6 NORTH AMERICA 37
6.1 North America Nanoparticle Drug Delivery Systems Market Size (2016-2027) 37
6.2 North America Nanoparticle Drug Delivery Systems Market Size by Type 37
6.2.1 North America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) 37
6.2.2 North America Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) 38
6.2.3 North America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027) 38
6.3 North America Nanoparticle Drug Delivery Systems Market Size by Application 39
6.3.1 North America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) 39
6.3.2 North America Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) 39
6.3.3 North America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027) 40
6.4 North America Nanoparticle Drug Delivery Systems Market Size by Country 40
6.4.1 North America Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) 40
6.4.2 North America Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) 41
6.4.3 United States 42
6.4.4 Canada 43
6.4.5 Mexico 44
7 EUROPE 45
7.1 Europe Nanoparticle Drug Delivery Systems Market Size (2016-2027) 45
7.2 Europe Nanoparticle Drug Delivery Systems Market Size by Type 45
7.2.1 Europe Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) 45
7.2.2 Europe Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) 46
7.2.3 Europe Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027) 46
7.3 Europe Nanoparticle Drug Delivery Systems Market Size by Application 47
7.3.1 Europe Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) 47
7.3.2 Europe Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) 47
7.3.3 Europe Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027) 48
7.4 Europe Nanoparticle Drug Delivery Systems Market Size by Country 48
7.4.1 Europe Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) 48
7.4.2 Europe Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) 49
7.4.3 Germany 50
7.4.4 France 51
7.4.5 U.K. 52
7.4.6 Italy 53
7.4.7 Russia 54
8 ASIA-PACIFIC 55
8.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size (2016-2027) 55
8.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type 55
8.2.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) 55
8.2.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) 56
8.2.3 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027) 56
8.3 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application 57
8.3.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) 57
8.3.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) 57
8.3.3 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027) 58
8.4 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region 58
8.4.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2016-2021) 58
8.4.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2022-2027) 59
8.4.3 China 60
8.4.4 Japan 61
8.4.5 South Korea 62
8.4.6 Southeast Asia 63
8.4.7 India 64
8.4.8 Australia 65
9 SOUTH AMERICA 66
9.1 South America Nanoparticle Drug Delivery Systems Market Size (2016-2027) 66
9.2 South America Nanoparticle Drug Delivery Systems Market Size by Type 66
9.2.1 South America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) 66
9.2.2 South America Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) 67
9.2.3 South America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027) 67
9.3 South America Nanoparticle Drug Delivery Systems Market Size by Application 68
9.3.1 South America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) 68
9.3.2 South America Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) 68
9.3.3 South America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027) 69
9.4 South America Nanoparticle Drug Delivery Systems Market Size by Country 69
9.4.1 South America Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) 69
9.4.2 South America Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) 70
9.4.3 Brazil 71
10 MIDDLE EAST & AFRICA 72
10.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size (2016-2027) 72
10.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type 72
10.2.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) 72
10.2.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) 73
10.2.3 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027) 73
10.3 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application 74
10.3.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) 74
10.3.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) 74
10.3.3 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027) 75
10.4 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country 75
10.4.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) 75
10.4.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) 76
10.4.3 Middle East 77
10.4.4 Africa 77
11 KEY PLAYERS PROFILES 78
11.1 Johnson & Johnson 78
11.1.1 Johnson & Johnson Company Details 78
11.1.2 Johnson & Johnson Business Overview 78
11.1.3 Johnson & Johnson Nanoparticle Drug Delivery Systems Introduction 79
11.1.4 Johnson & Johnson Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 80
11.1.5 Johnson & Johnson Recent Development 81
11.2 Sun Pharmaceutical 81
11.2.1 Sun Pharmaceutical Company Details 81
11.2.2 Sun Pharmaceutical Business Overview 82
11.2.3 Sun Pharmaceutical Nanoparticle Drug Delivery Systems Introduction 82
11.2.4 Sun Pharmaceutical Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 83
11.3 CSPC 83
11.3.1 CSPC Company Details 83
11.3.2 CSPC Business Overview 84
11.3.3 CSPC Nanoparticle Drug Delivery Systems Introduction 85
11.3.4 CSPC Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 85
11.4 Kinyond 86
11.4.1 Kinyond Company Details 86
11.4.2 Kinyond Business Overview 86
11.4.3 Kinyond Nanoparticle Drug Delivery Systems Introduction 86
11.4.4 Kinyond Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 87
11.5 Teva 88
11.5.1 Teva Company Details 88
11.5.2 Teva Business Overview 88
11.5.3 Teva Nanoparticle Drug Delivery Systems Introduction 89
11.5.4 Teva Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 89
11.5.5 Teva Recent Development 89
11.6 Fudan-Zhangjiang 90
11.6.1 Fudan-Zhangjiang Company Details 90
11.6.2 Fudan-Zhangjiang Business Overview 91
11.6.3 Fudan-Zhangjiang Nanoparticle Drug Delivery Systems Introduction 91
11.6.4 Fudan-Zhangjiang Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 92
11.7 Zydus Cadila 93
11.7.1 Zydus Cadila Company Details 93
11.7.2 Zydus Cadila Business Overview 93
11.7.3 Zydus Cadila Nanoparticle Drug Delivery Systems Introduction 94
11.7.4 Zydus Cadila Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 94
11.8 TTY Biopharma 94
11.8.1 TTY Biopharma Company Details 94
11.8.2 TTY Biopharma Business Overview 95
11.8.3 TTY Biopharma Nanoparticle Drug Delivery Systems Introduction 95
11.8.4 TTY Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 96
11.9 Pacira 96
11.9.1 Pacira Company Details 96
11.9.2 Pacira Business Overview 97
11.9.3 Pacira Nanoparticle Drug Delivery Systems Introduction 97
11.9.4 Pacira Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 98
11.9.5 Pacira Recent Development 98
11.10 Luye Pharma 100
11.10.1 Luye Pharma Company Details 100
11.10.2 Luye Pharma Business Overview 100
11.10.3 Luye Pharma Nanoparticle Drug Delivery Systems Introduction 101
11.10.4 Luye Pharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 101
11.11 Leadiant Biosciences 102
11.11.1 Leadiant Biosciences Company Details 102
11.11.2 Leadiant Biosciences Business Overview 102
11.11.3 Leadiant Biosciences Nanoparticle Drug Delivery Systems Introduction 103
11.11.4 Leadiant Biosciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 103
11.11.5 Leadiant Biosciences Recent Development 103
11.12 Ipsen 104
11.12.1 Ipsen Company Details 104
11.12.2 Ipsen Business Overview 105
11.12.3 Ipsen Nanoparticle Drug Delivery Systems Introduction 105
11.12.4 Ipsen Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 106
11.12.5 Ipsen Recent Development 106
11.13 Sayre Therapeutics 108
11.13.1 Sayre Therapeutics Company Details 108
11.13.2 Sayre Therapeutics Business Overview 108
11.13.3 Sayre Therapeutics Nanoparticle Drug Delivery Systems Introduction 109
11.13.4 Sayre Therapeutics Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 110
11.13.5 Sayre Therapeutics Recent Development 110
11.14 Jazz 111
11.14.1 Jazz Company Details 111
11.14.2 Jazz Business Overview 111
11.14.3 Jazz Nanoparticle Drug Delivery Systems Introduction 112
11.14.4 Jazz Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 112
11.14.5 Jazz Recent Development 112
11.15 Alnylam 114
11.15.1 Alnylam Company Details 114
11.15.2 Alnylam Business Overview 114
11.15.3 Alnylam Nanoparticle Drug Delivery Systems Introduction 115
11.15.4 Alnylam Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 115
11.15.5 Alnylam Recent Development 116
11.16 Bausch Health 117
11.16.1 Bausch Health Company Details 117
11.16.2 Bausch Health Business Overview 118
11.16.3 Bausch Health Nanoparticle Drug Delivery Systems Introduction 118
11.16.4 Bausch Health Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 119
11.16.5 Bausch Health Recent Development 119
11.17 Acrotech Biopharma 120
11.17.1 Acrotech Biopharma Company Details 120
11.17.2 Acrotech Biopharma Business Overview 120
11.17.3 Acrotech Biopharma Nanoparticle Drug Delivery Systems Introduction 121
11.17.4 Acrotech Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 121
11.17.5 Acrotech Biopharma Recent Development 122
11.18 Takeda 123
11.18.1 Takeda Company Details 123
11.18.2 Takeda Business Overview 123
11.18.3 Takeda Nanoparticle Drug Delivery Systems Introduction 124
11.18.4 Takeda Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 124
11.18.5 Takeda Recent Development 124
11.19 Chiesi Farmaceutici 126
11.19.1 Chiesi Farmaceutici Company Details 126
11.19.2 Chiesi Farmaceutici Business Overview 127
11.19.3 Chiesi Farmaceutici Nanoparticle Drug Delivery Systems Introduction 127
11.19.4 Chiesi Farmaceutici Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 127
11.20 Gilead Sciences 128
11.20.1 Gilead Sciences Company Details 128
11.20.2 Gilead Sciences Business Overview 128
11.20.3 Gilead Sciences Nanoparticle Drug Delivery Systems Introduction 129
11.20.4 Gilead Sciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) 129
11.20.5 Gilead Sciences Recent Development 130
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 131
13 APPENDIX 132
13.1 Research Methodology 132
13.1.1 Methodology/Research Approach 132
13.1.2 Data Source 135
13.2 Disclaimer 138
13.3 Author Details 138